RecruitingNCT01793168
Rare condition
Infantile hypophosphatasia
1
studies recruiting now
as of 7 Sept 2026
5
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
15 Feb 2013
most recent study posted
among recruiting studies
Recruiting trials
Showing the 1 most recently updated recruiting study, as recorded 7 Sept 2026. Live status on each study page.
Search all Infantile hypophosphatasia studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Infantile hypophosphatasia study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Infantile hypophosphatasia
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (ALPL).
Treatments being studied
4 approved treatments and 6 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Lanthanum Carbonate (Fosrenol)Approved: Calcium Acetate (Calcium acetate)Approved: Sevelamer Hydrochloride (Renagel)Approved: Asfotase Alfa (Strensiq)
Phase 3Burosumab (Crysvita)
Phase 3Efzimfotase Alfa
Phase 3Sbr-759
Phase 3Bixalomer
Phase 2Setrusumab
Phase 1Oxylanthanum Carbonate
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).